Barry Sandall Email & Phone Number

San Diego, California, Us

Leading Strategic Planning and Business Development for Mainstay Medical, a global medical device company focused on treating patients with Chronic Low Back Pain. ReActiv8, Mainstay's implantable neurostimulation therapy system, received FDA approval in June 2020.- Leading development and analysis of corporate and board dashboards and KPI analytics - Running all Executive Team meetings and corporate performance process- Owning corporate goal setting and tracking (Annual and Quarterly)- Spearheading Strategic Planning and Corporate performance process across all functions (International, US Commercial, Marketing, Operations, Product Development, Clinical, Quality and Regulatory, Scientific Affairs, Finance, HR, Legal, and Reimbursement)

Amsterdam, Noord-Holland, Nl

Promoted to Business Integration leader (2019-2020) responsible for remaining business integration activities for Philips' 2017 acquisition of Spectranetics, a merger of Philips' medical device businesses (Volcano - 2015 acquisition, $1B; Spectranetics - 2017 acquisition, $2.2B).- Executive reporting- Integration/IMO program management- Key Strategic projectsCommercial M&A integration lead (US and International, commercial sales force, commercial operations, training and education, marketing and branding) for Philips' $360M acquisition of Intact Vascular (Sep 2020).

Amsterdam, Noord-Holland, Nl

Integration Management Office (IMO) for $2.2B acquisition of Spectranetics (closed Aug 2017). - Finance, integration KPI reporting, and executive deck creation- Synergy management- Commercial functions program management- Strategy function integrationPhilips IGTD (medical devices)

Amsterdam, Noord-Holland, Nl

Commercial Operations, Go-to Market Strategy, and Key Strategic Projects:- Reimbursement analysis- New business model generation (Capital, Disposable, Service, and Financing solutions programs)- Commercial analyticsPhilips IGTD (medical devices)

Amsterdam, Noord-Holland, Nl

Business case development for strategic licensing play for product line extension:- Primary research with physicians, case workflow; Secondary market, competitive research- Financial return modeling & investment recommendation to VP, SVP executivesPhilips IGTD (medical device business), Coronary category

San Diego, Ca, Us

(#1) 50 Smartest Companies - MIT Technology Review 2014 (#36) Forbes - World's 100 Most Innovative Companies 2014Global biotech company ($1.8B 2014 Revenue) focused on improving human health by unlocking the power of the genome.

Chicago, Il, Us

Oncology research program management;Reporting to Chair, Department of Pediatrics

Los Angeles, California, Us

Midwest Cleantech Open - startup accelerator for cleantech and energy startups. Program management and advisor to 20-startup class.

Chicago, Il, Us

Immunology Research;Dept. of Pathology

Boston, Ma, Us

Immunology research program management and lab supervision;Reporting to Chief, Pulmonary and Critical Care Unit

Master Of Business Administration (M.B.A.), Strategic Management

Bachelor Of Science - Bs, Biology/Biological Sciences, General